4V.Barriales Alvarez,C.Moris de la Tassa,I.Sanchez Posada,et al.The etiology and associated risk factors in a sample of 300 patients with atrial fibrillation[J].Rev Esp Cardiol,1999,52(6):403-414.
5Ostgren CJ,Merlo J,Rastam L,et al.Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community[J].Diabetes Obes Metab,2004,6(5):367-374.
6Healey JS,Connolly SJ.Atrial fibrillation:hypertension as a causative agent,risk factor for complication,and potential therapeutic target[J].Am J Cardiol,2003,91:9G-14G.
7Wattigney WA,Mensah GA,Croft JB.Increasing trends in hospitalization for atrial fibrillation in the United States,1985 through 1999:implications for primary prevention[J].Circulation,2003,108(6):711-716.
8Walker AM,Bennett D.Epidemiology and outcomes in patients with atrial fibrillation in the United States[J].Heart Rhythm,2008,5(10):1365-1372.
9Stuart J,Connolly,Michael D,et al.Dabigatran versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2009,361:1139-1151.
10Almdal T,Scharling H,Jensen JS,et al.The independent effect of type 2 diabetes mellitus on ischemic heart disease,stroke,and death:a population-based study of 13000 men and women with 20 years of follow-up[J].Arch Intern Med,2004,164:1422-1426.
